Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...

H.C. Wainwright analyst Joseph Pantginis has maintained their bullish stance on BMEA stock, giving a Buy rating yesterday.Stay Ahead of the ...

Biomea Fusion (BMEA) announced the company will become a diabetes and obesity medicines company. Based on the most recent clinical trial ...

Dubai, UAE , Jan. 13, 2025 (GLOBE NEWSWIRE) -- The Bakeneko team is targeting the Brazilian market with a focused marketing ...

Icovamenib & BMF-650 (oral small molecule GLP-1) are the cornerstones of the metabolic franchiseBiomea preparing icovamenib for late-stage clinical development2025 corporate update to be presented at ...

D. Boral Capital reiterated their buy rating on shares of Biomea Fusion (NASDAQ:BMEA – Free Report) in a report issued on ...

Jan. 07, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing ...

Commonwealth Fusion Systems (CFS), a subsidiary of MIT, has announced plans to build the first commercial power plant harnessing nuclear fusion energy there. A worker inside the vacuum chamber of a ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in lean muscle mass ...

Biomea Fusion, Inc. New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight reduction and 43% increase in ...